79137568 - PHARNEXT

Information

  • Trademark
  • 79137568
  • Serial Number
    79137568
  • Registration Number
    4611799
  • Filing Date
    June 20, 2013
    12 years ago
  • Registration Date
    September 30, 2014
    10 years ago
  • Transaction Date
    January 07, 2024
    a year ago
  • Status Date
    June 21, 2023
    2 years ago
  • Published for Opposition Date
    July 15, 2014
    11 years ago
  • Location Date
    September 15, 2015
    9 years ago
  • Status Code
    404
  • Current Location
    POST REGISTRATION
    Employee Name
    HALMEN, KATHERINE E
  • Attorney Docket Number
    CREG-0102-T
    Attorney Name
    Jeffrey A. Smith
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
3000
Mark Identification
PHARNEXT
Case File Statements
  • GS0411: Training services in the field of medicine; publishing of books and texts * in field of medicine *, namely, press articles, magazines, brochures; electronic publishing services, namely, publication of texts works of others on-line in the field of medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions and seminars in the field of medicine for non-business and non-commercial purposes; * teaching in the field of medicine *
  • DM0000: The mark consists of the word "PHARNEXT" appearing in blue to the right of a design comprised of incomplete circles in the colors blue, red and green. In the center of the incomplete circles is a blue circle. The color white in the mark represents background and is not a feature of the mark.
  • B00001: In the statement, page 2, line 1through line 5, should be deleted, and "Database management and collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics in the field of health and medicine; collection and systematization of information into computer databases in the field of health and medicine; public relations in the field of health and medicine;" communication, namely, promoting public awareness regarding disease treatments." should be inserted. In the statement page 2, line 7 through line 13, should be deleted, and "Training services in the field of medicine; publishing of books and texts in field of health and medicine, namely, press articles, magazines, brochures; electronic publishing services, namely, publication of texts works of others on-line in the field of medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions and seminars in the field of medicine for non-business and non-commercial purposes; teaching in the field of health and medicine" should be inserted. In the statement, page 2 line 21, after software "in the field of health and medicine" should be inserted.
  • GS0051: Biological preparations for medical purposes for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II; medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II; pharmaceutical preparations for human use for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; diagnostic preparations for medical diagnosis purposes; chemicals preparations for medical purposes, namely, for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; food supplements and nutritional supplements; dietetic food supplements for medical use; homeopathic and plant therapy compositions, namely, homeopathic supplements; sanitary preparations for medical use; pharmaceuticals preparations for skin care, hair care and hygiene; medical preparations for slimming; therapeutic medicated bath preparations; bath salts for medical use; dietary supplement beverages, namely, dietary supplemental drinks in the nature of vitamin and mineral beverages; appetite suppressants for medical use; barks for pharmaceutical use, namely, angostura bark for medical purposes, condurango bark for medical purposes, Croton bark for medical purposes and Croton bark for use as an anti-inflammatory; royal jelly for medical purposes; medicinal oils for medical use; chemical reagents for medical use, namely, biomarkers
  • B00002: In the statement, Page 2, line 3, line 5, line 6, line 10, line 16, and line 25 "HEALTH AND" should be deleted.
  • PM0000: PHAR NEXT
  • CC0000: The color(s) red, green and blue is/are claimed as a feature of the mark.
  • GS0351: Database management and collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics * in the field of medicine *; collection and systematization of information into computer databases * in the field of medicine *; public relations* in the field of medicine * ; communication, namely, promoting public awareness regarding disease treatments
  • GS0441: Medical services; pharmaceutical advice
  • GS0421: Pharmaceutical research and development; scientific research in the field of medicine; conducting of clinical trials and studies; chemical and biological analysis; laboratory research in the field of cosmetics, chemistry, bacteriology, biology, biotechnology and nutrition; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemicals, biological agents and pharmaceuticals; design and development of software * in the field of medicine *; scientific laboratory services; provision of information in the field of pharmaceuticals research, medical research and scientific research in the field of pharmaceuticals and clinical trials; chemical research on chemical reagents for medical use, namely, biomarkers
Case File Event Statements
  • 1/6/2024 - a year ago
    55 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC
  • 1/6/2024 - a year ago
    54 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 4/17/2023 - 2 years ago
    53 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/9/2022 - 3 years ago
    52 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/4/2022 - 3 years ago
    51 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 4/22/2022 - 3 years ago
    50 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 4/22/2022 - 3 years ago
    49 - INVALIDATION PROCESSED Type: INPC
  • 12/16/2021 - 3 years ago
    48 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 4/16/2021 - 4 years ago
    47 - CANCELLED SECTION 71 Type: C71T
  • 9/30/2019 - 5 years ago
    46 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 6/6/2019 - 6 years ago
    45 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/7/2017 - 8 years ago
    44 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/8/2017 - 8 years ago
    43 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/26/2017 - 8 years ago
    42 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/23/2016 - 9 years ago
    41 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 5/15/2016 - 9 years ago
    40 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 9/15/2015 - 9 years ago
    39 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 9/15/2015 - 9 years ago
    38 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/30/2015 - 10 years ago
    37 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 6/29/2015 - 10 years ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 5/15/2015 - 10 years ago
    35 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 2/6/2015 - 10 years ago
    34 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/31/2014 - 10 years ago
    33 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/31/2014 - 10 years ago
    32 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/30/2014 - 10 years ago
    31 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/30/2014 - 10 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/15/2014 - 10 years ago
    29 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 9/11/2014 - 10 years ago
    28 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 7/22/2014 - 11 years ago
    27 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 7/15/2014 - 11 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/15/2014 - 11 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/2/2014 - 11 years ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/2/2014 - 11 years ago
    23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 6/25/2014 - 11 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/10/2014 - 11 years ago
    21 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/5/2014 - 11 years ago
    20 - ASSIGNED TO LIE Type: ALIE
  • 5/22/2014 - 11 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/22/2014 - 11 years ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/22/2014 - 11 years ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/22/2014 - 11 years ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/22/2014 - 11 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/7/2014 - 11 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/7/2014 - 11 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/7/2014 - 11 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/6/2014 - 11 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/6/2014 - 11 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/23/2013 - 11 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/7/2013 - 11 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/7/2013 - 11 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 11/7/2013 - 11 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 11/6/2013 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/1/2013 - 11 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/28/2013 - 11 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/28/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/25/2013 - 11 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR